| 例数 | n = 157 |
| 接种疫苗后天数 | 47, (32~79) |
| 年龄(岁) | 51, (45~60) |
| 体重指数(kg/m2) | 22.00, (20.70~24.49) |
| 疫苗类型 |
|
| BBIBP-CorV (国药生物)，n (%) | 83, (52.8) |
| CoronaVac (北京科兴)，n (%) | 50, (31.8) |
| Zhifei Longcom China (安徽智飞)，n (%) | 24, (15.4) |
| 性别 |
|
| 女性，n (%) | 51, (32.4) |
| 男性，n (%) | 106, (67.6) |
| TNM分期 |
|
| TNM1, n (%) | 27, (17.2) |
| TNM2, n (%) | 83, (52.8) |
| TNM3, n (%) | 29, (18.4) |
| TNM4, n (%) | 18, (11.4) |
| ASA分级 |
|
| ASA1, n (%) | 31, (19.7) |
| ASA2, n (%) | 53, (33.7) |
| ASA3, n (%) | 73, (46.6) |
| 积极治疗 |
|
| 否，n (%) | 50, (31.8) |
| 是，n (%) | 107, (68.2) |
| 化疗 |
|
| 否，n (%) | 100, (63.7) |
| 是，n (%) | 57, (36.3) |
| RBD抗体阳性 |
|
| 否，n (%) | 46, (29.3) |
| 是，n (%) | 111, (70.7) |
| 中和抗体阳性 |
|
| 否，n(%) | 57, (36.3) |
| 是，n(%) | 100, (63.7) |
| 红细胞计数(1012/L) | 4.230, (3.720~4.700) |
| 白细胞计数(109/L) | 6.140, (4.750~7.740) |
| 淋巴细胞计数(109/L) | 1.310, (0.910~1.630) |
| 白蛋白(g/L) | 40.5, (35.5~48.2) |
| RBD特异性B细胞 | 9.83, (6.60~13.88) |
| 静息B细胞 | 16.15, (11.00~22.70) |
| 中间B细胞 | 41.50, (30.00~48.60) |
| 活化B细胞 | 16.35, (11.30~21.90) |
| 非典型B细胞 | 23.30, (18.20~30.80) |